Investor Eye: Juno Capital Believes Medtech Is An Optimal Long-Term Investment
Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors.
You may also be interested in...
Unmet needs are at the core of Endeavour Vision’s investment strategy, accepting that payment models may need to change as patients become more directly involved in device development.
In an interview with Medtech Insight, co-author of The Digital Pill, Elgar Fleisch proselytized the benefits of digital health, explaining how particular innovations could solve problems in health care.
Start-Up Spotlight: Resonant Link Plans To Electrify Device Industry With Efficient Wireless Charging Technology
The company is commercializing technology developed at Dartmouth and Stanford universities, hoping that its technology will reduce the size and complication rates of implantable devices.